Spain·Buyer: Gerencia del Area de Atención Integrada de Guadalajara
PNSP 7-2026 Adquisición de los principios activos Interferon Beta 1A, Nusinersen, Natalizumab, Diroximel y Fumarato (Biogen Spain, S.L.U.) para la GAI de Guadalajara
Awarded·11 May 2026·EUR 1,350,832
Otnox Intelligence Summary
Deadline
16.04.2026
Published
11.05.2026
Awarded
11.05.2026
Awarded
11.06.2026
See full tender intelligence
All winners, buyer history, related tenders and AI insights.